Krka Underlines Message On Entering Biosimilars Arena In Europe
Slovenian Firm Open For Regulatory And Marketing Collaboration
Krka’s management discussed the firm’s latest perception of the European biosimilars market, as it reported financial results for the nine months to 30 September.
